Neuphoria Therapeutics

NEUP

2.7600.72% ( -0.020 )

已收盘: 11月9日 16:00:00 (美东)

主要股东最新
股东
Lynx1 Capital Management LP	16.18%	87.53 万	0.00%	+0	2026/09/17
AdvisorShares Investments, LLC	5.78%	31.29 万	1.11%	+6.00 万	2026/09/30
Coastlands Capital LP	4.22%	22.86 万	2.01%	+10.86 万	2026/07/23
Vanguard Capital Management, LLC	3.83%	20.73 万	1.37%	+7.52 万	2026/06/30
Shay Capital LLC	2.88%	15.58 万	0.07%	+4,812.00	2026/06/30
Balyasny Asset Management L.P.	2.63%	14.22 万	0.02%	+45.00	2026/06/30
Citadel Advisors LLC	1.34%	7.26 万	0.98%	+5.32 万	2026/06/30
Geode Capital Management, LLC	0.94%	5.06 万	0.02%	+1,120.00	2026/09/30
Ikarian Capital, LLC	0.88%	4.74 万	<0.01%	+0	2026/06/30
ADAR1 Capital Management, LLC	0.55%	3.00 万	<0.01%	+0	2026/06/30
Renaissance Technologies LLC	0.47%	2.55 万	--	+2.55 万	2026/06/30
XTX Markets Limited	0.43%	2.31 万	0.43%	+2.31 万	2026/06/30
Hudson River Trading LLC	0.42%	2.29 万	--	+2.29 万	2026/06/30
Jane Street Group, LLC	0.28%	1.49 万	0.28%	+1.49 万	2026/06/30
Boothbay Fund Management, LLC	0.26%	1.40 万	<0.01%	+0	2026/06/30
Alan FisherIndependent Non-Executive Chair of the Board	0.25%	1.36 万	0.25%	+1.36 万	2026/09/17
Northern Trust Global Investments	0.20%	1.06 万	--	+1.06 万	2026/06/30
MRL Ventures Fund LLC	0.19%	1.00 万	<0.01%	+0	2026/06/30
Jane RyanIndependent Non-Executive Director	0.13%	7,013.00	0.13%	+6,783.00	2026/09/17
Peter Miles DaviesIndependent Non-Executive Director	0.13%	6,909.00	0.13%	+6,783.00	2026/09/17

全部股东